Foresite Capital Management V, LLC

10% owner

Foresite Capital Management V, LLC (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in Latigo Biotherapeutics, Inc. (LTGO). Across 1 priced purchase filing, the average 21-session return was +31.1% from execution and +31.1% from disclosure (delay-adjusted; derived). The largest single filing was $2.5M of LTGO (140,000 sh × $18.00, as filed), executed Aug 10.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+31.1%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+31.1%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.5M

shares × price, as filed

Last traded

Aug 10

Filed Aug 10

Median ADV $61.3M across their filed names

Open performance→

Volume by month

Buys $2.5M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

LTGO

Latigo Biotherapeutics, Inc. LTGO · 1 buy · 0 sells 1 filing

Recent filings

LTGOPURCHASE Latigo Biotherapeutics, Inc. View filing → $2.5M
140,000 sh × $18.00
Exec Aug 10
Filed Aug 10 · 8:21 PM ET